Digoxin is used chronically in the therapy of cardiac arrhythmias, especially atrial fibrillation, atrial flutter and heart failure. It is the most effective medicine for the treatment of heart failure, and a third line medication in the treatment of irregular heartbeat. It is normally administered orally as tabs but can also be given intravenously under urgent circumstances.
This report contains market size and forecasts of Digoxin API in global, including the following market information:
Global Digoxin API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Digoxin API Market Sales, 2017-2022, 2023-2028, (Kiloton)
Global top five Digoxin API companies in 2021 (%)
The global Digoxin API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity: ≥98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Digoxin API include C2 Pharma, Alkaloids Corporation, Vital Labs and Alchem, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Digoxin API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Digoxin API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Digoxin API Market Segment Percentages, by Type, 2021 (%)
Purity: ≥98%
Purity: <98%
Global Digoxin API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Digoxin API Market Segment Percentages, by Application, 2021 (%)
Tablet Product
Injection Product
Global Digoxin API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Digoxin API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Digoxin API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Digoxin API revenues share in global market, 2021 (%)
Key companies Digoxin API sales in global market, 2017-2022 (Estimated), (Kiloton)
Key companies Digoxin API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
C2 Pharma
Alkaloids Corporation
Vital Labs
Alchem